Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0205700 (
ash
)
15,125
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Waste ashes from three types of hospital waste (HW) incinerators, built in
SARS
(
Severe Acute Respiratory Syndrome
) period and currently running in China, were collected and polycyclic aromatic hydrocarbons (PAH) properties in the ashes were investigated. The mean summation PAH levels in the waste ashes varied widely from 4.16 mg kg(-1) to 198.92 mg kg(-1), and the mean amounts of carcinogenic PAHs ranged from 0.74 to 96.77 mg kg(-1), exceeding the limits regulated by several countries. Among the three types of incinerators, two medium-scale incinerators generated relatively high levels of PAHs (mean summation PAH 22.50 and 198.92 mg kg(-1)) compared to small-scale and large-scale incinerators (mean summation PAH 4.16 and 16.43 mg kg(-1)). Bottom ashes were dominated by low molecular weight PAHs (LM-PAH; containing two- to three-ringed PAHs) and medium molecular weight PAHs (MM-PAH; containing four-ringed PAHs), while fly ashes were abundant in MM-PAH and high molecular weight PAHs (HM-PAH, containing five- to six-ringed PAHs). Statistical analysis indicated that there was a positive relationship (R2=0.88) between organic matter and total PAHs thus it has the potential to be used as an indicator for PAHs in HW ashes. Moreover, it was found that PAHs in the ashes correlated highly with some metallic elements either positively (e.g. Fe, Ti, Mg) or negatively (Ca), indicating that these elements might promote or prevent PAH formation during HW combustion. Although bottom
ash
resulted from HW incinerators has not been classified as hazardous material, the results of this study indicated that this type of waste
ash
contained high levels of PAHs thus need special treatment before landfill.
...
PMID:Levels of polycyclic aromatic hydrocarbons in different types of hospital waste incinerator ashes. 1844 54
Incineration has become the main mechanism for hospital waste (HW) disposal in China after the outbreak of
Severe Acute Respiratory Syndrome
(
SARS
) in 2003. However, little information is available on the chemical properties of the resulting ashes. In the present study, 22HW
ash
samples, including 14 samples of bottom
ash
and eight samples of fly
ash
, were collected from four typical HW incineration plants located across China. Chemical analysis indicated that the HW ashes contained large amounts of metal salts of Al, Ca, Fe, K, Mg, Na with a concentration range of 1.8-315gkg(-1). Furthermore, the ashes contained high concentrations of heavy metals such as Ag, As, Ba, Bi, Cd, Cr, Cu, Mn, Ni, Pb, Ti, Sb, Sn, Sr, Zn with a vast range of 1.1-121,411mgkg(-1), with higher concentrations found in the fly
ash
samples. Sequential extraction results showed that Ba, Cr, Ni and Sn are present in the residual fraction, while Cd existed in the exchangeable and carbonate fractions. As, Mn, Zn existed in the Fe-Mn oxide fraction, Pb was present in the Fe-Mn oxide and residual fractions, and Cu was present in the organic matter fraction. Furthermore, toxicity characteristic leaching procedure (TCLP) results indicated that leached amounts of Cd, Cu and Pb from almost all fly
ash
samples exceeded the USEPA regulated levels. A comparison between the HW ashes and municipal solid waste (MSW)
ash
showed that both HW bottom
ash
and fly
ash
contained higher concentrations of Ag, As, Bi, Cd, Cr, Cu, Pb, Ti, and Zn. This research provides critical information for appropriate HW incineration
ash
management plans.
...
PMID:Chemical properties of heavy metals in typical hospital waste incinerator ashes in China. 1899 May 57
Objective:
Social distancing and hand washing with soap and water have been advocated as the main proactive measures against the spread of coronavirus. We sought to find out what other alternative materials and methods would be used among populations without running water and who may not afford alcohol-based sanitizers.
Results:
We reviewed studies that reported use of sand, soil,
ash
, soda
ash
, seawater, alkaline materials, and sunlight as possible alternatives to handwashing with soap and water. We identified the documented mechanism of actions of these alternative wash methods on both inanimate surfaces and at cellular levels. The consideration of use of these alternative locally available in situations of unavailability of soap and water and alcohol-based sanitizers is timely in the face of coronavirus pandemic. Further randomized studies need to be carried out to evaluate the effectiveness of these alternatives in management of
SARS
-Cov-2.
...
PMID:Dry Taps? A Synthesis of Alternative "Wash" Methods in the Absence of Water and Sanitizers in the Prevention of Coronavirus in Low-Resource Settings. 3257 77
In December 2019, severe cases of pneumonia of unknown aetiology were reported in Wuhan city, in China. Lately, the pneumonia was related to the
severe acute respiratory syndrome
coronavirus-2 (SARS-CoV-2), and the diseases was termed coronavirus disease-2019 (COVID-19). At the end of January 2020, the infection spread all over Italy, but with high infection rates and mortality in the northern part, especially in Lombardy, the most industrialized and polluted region of the country. It is noteworthy that a strong association between severe viral respiratory disease and air pollution has been described. Air pollutant could be solid particles, liquid droplets, or gases and can be of natural origin (such as
ash
from a volcanic eruption) or released from motor vehicle depletes (carbon monoxide gas) or factories (sulfur dioxide). Volcanic eruptions release large amounts of sulphuric acid, hydrogen sulfide, and hydrochloric acid into the atmosphere. Pulmunary diseases spreadby means of small droplets in thebreath, also called aerosols, and air pollution may facilitate the outside survival of viruses. We suppose that
ash
and gases emitted from the Mount Etna contributed to air pollution, potentially favouring the major contagion of COVID-19 in the eastern flank of the mountain, as in Catania city. In fact,
ash
and gases (with regard to radon) are usually particularly intense in winter, with a reduction of emission of specific metals with warmer weather. This is the first paper that elaborates the hypothesis of a potential role of volcanic gases and heavy metals-related air pollution, combined to specific climatic conditions and regional topography, in favouring severe COVID-19 diffusion in Sicily. Clinical and epidemiological studies are needed to support the hypothesis and plan the due prevention and awareness-raising campaigns.
...
PMID:Can volcanic trace elements facilitate Covid-19 diffusion? A hypothesis stemming from the Mount Etna area, Sicily. 3275 94
The ongoing COVID-19 pandemic is the most trending and talked topic across the World. From its point of origin in Wuhan, China to clinical laboratory at NIH, a mere six-month-old
SARS
-CoV-2 virus is keeping the clinicians, and scientists busy at various fronts. However, COVID-19 is an emerging and evolving disease and each day brings in more data, new figures, and findings from the field of clinical practice. The role of hematologists has been increasingly recognized during the current pandemic because of several reasons. Most important of them are the characteristic hematological findings of COVID-19 patients that also have prognostic implications and that were not seen in other viral infections. The treatment of hematological complications in COVID-19 patients is very challenging given the critical care setting. There are interim and limited guidelines thus far due to the novelty of the disease. As this remains to be a quite fluid situation, all the appropriate medical societies including the major hematology bodies are proposing initial and interim guidelines (e.g.
ASH
guideline). This puts a hematologist on consult service in a dubious position where, he/she must tailor the recommendations on case to case basis. The purpose of this review is to provide the background context about the impact of COVID-19 on the blood system and to summarize the current interim guidelines to manage the associated hematological issues in COVID-19 infection.
...
PMID:A review on how to do hematology consults during COVID-19 pandemic. 3319 84
Coronavirus disease 2019 (COVID-19) is an illness resulting from
severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) that emerged in late 2019. Patients with cancer, and especially those with hematologic malignancies, may be at especially high risk of adverse outcomes, including mortality resulting from COVID-19 infection. The
ASH
Research Collaborative COVID-19 Registry for Hematology was developed to study features and outcomes of COVID-19 infection in patients with underlying blood disorders, such as hematologic malignancies. At the time of this report, data from 250 patients with blood cancers from 74 sites around the world had been entered into the registry. The most commonly represented malignancies were acute leukemia (33%), non-Hodgkin lymphoma (27%), and myeloma or amyloidosis (16%). Patients presented with a myriad of symptoms, most frequently fever (73%), cough (67%), dyspnea (50%), and fatigue (40%). Use of COVID-19-directed therapies, such as hydroxychloroquine (n = 76) or azithromycin (n = 59), was common. Overall mortality was 28%. Patients with a physician-estimated prognosis from the underlying hematologic malignancy of <12 months at the time of COVID-19 diagnosis and those with relapsed/refractory disease experienced a higher proportion of moderate/severe COVID-19 disease and death. In some instances, death occurred after a decision was made to forgo intensive care unit admission in favor of a palliative approach. Taken together, these data support the emerging consensus that patients with hematologic malignancies experience significant morbidity and mortality resulting from COVID-19 infection. Batch submissions from sites with high incidence of COVID-19 infection are planned to support future analyses.
...
PMID:Outcomes of patients with hematologic malignancies and COVID-19: a report from the ASH Research Collaborative Data Hub. 3327 1